12.01.14
Lombard Medical Inc. has named veteran finance and medical technology executive William J. Kullback as chief financial officer (CFO).
“On behalf of the Lombard Medical team, I am very pleased to welcome Bill to the company,” said CEO Simon Hubbert. “With more than two decades of CFO and medical technology industry leadership experience, Bill brings extensive understanding of the U.S. public equity and debt capital markets to the company, having played key roles in a variety of significant corporate transactions. His strategic skills and expertise will be invaluable as we continue to build our global operations and deliver value to shareholders.”
Kullback brings more than 30 years of broad corporate finance and accounting experience to Lombard Medical, including more than 20 years in chief financial officer roles ranging from large, publicly traded to privately held growth companies. His deep industry experience includes CFO positions at medical technology companies ActivStyle Inc., Angeion Corporation, IntriCon Corporation and MedSource Technologies Inc. Most recently, he served as partner, CFO and chief compliance officer of Integris LLC, a U.S. Securities and Exchange Commission-registered wealth management firm with more than $300 million in assets under management. Kullback received a B.A. in economics and English, as well as an MBA with a concentration in accounting, from the State University of New York at Buffalo.
Hubbert also thanks exiting CFO Ian Ardill for his contributions to the company. “This change is a natural evolution for Lombard Medical as we made the transition to a U.S.-based publicly traded company earlier this year, a significant milestone for the company in which Ian played a key role. Ian has been a big part of the culture and value created at Lombard Medical and we wish him all the best in his future endeavours.”
Lombard Medical makes devices for the treatment of abdominal aortic aneurysms. The company is based in Oxfordshire, England, with U.S. offices in Irvine, Calif.
“On behalf of the Lombard Medical team, I am very pleased to welcome Bill to the company,” said CEO Simon Hubbert. “With more than two decades of CFO and medical technology industry leadership experience, Bill brings extensive understanding of the U.S. public equity and debt capital markets to the company, having played key roles in a variety of significant corporate transactions. His strategic skills and expertise will be invaluable as we continue to build our global operations and deliver value to shareholders.”
Kullback brings more than 30 years of broad corporate finance and accounting experience to Lombard Medical, including more than 20 years in chief financial officer roles ranging from large, publicly traded to privately held growth companies. His deep industry experience includes CFO positions at medical technology companies ActivStyle Inc., Angeion Corporation, IntriCon Corporation and MedSource Technologies Inc. Most recently, he served as partner, CFO and chief compliance officer of Integris LLC, a U.S. Securities and Exchange Commission-registered wealth management firm with more than $300 million in assets under management. Kullback received a B.A. in economics and English, as well as an MBA with a concentration in accounting, from the State University of New York at Buffalo.
Hubbert also thanks exiting CFO Ian Ardill for his contributions to the company. “This change is a natural evolution for Lombard Medical as we made the transition to a U.S.-based publicly traded company earlier this year, a significant milestone for the company in which Ian played a key role. Ian has been a big part of the culture and value created at Lombard Medical and we wish him all the best in his future endeavours.”
Lombard Medical makes devices for the treatment of abdominal aortic aneurysms. The company is based in Oxfordshire, England, with U.S. offices in Irvine, Calif.